|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Gsinc
|
5.1K |
2.3M |
1 |
22:44 |
| 22:44 |
ASX - By Stock
|
5.1K
|
2.3M
|
1
|
|
|
ASX - By Stock
|
4DX |
Re:
down?
|
|
Gsinc
|
57 |
22K |
1 |
22:33 |
| 22:33 |
ASX - By Stock
|
57
|
22K
|
1
|
|
|
ASX - By Stock
|
4DX |
Re:
down?
|
|
Gsinc
|
57 |
22K |
17 |
13/03/26 |
| 13/03/26 |
ASX - By Stock
|
57
|
22K
|
17
|
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix Phase 3 Trial Last Patient Receives First Dose
|
|
Gsinc
|
66 |
17K |
10 |
10/03/26 |
| 10/03/26 |
ASX - By Stock
|
66
|
17K
|
10
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: S&P DJI Announces March 2026 Quarterly Rebalance
|
|
Gsinc
|
88 |
33K |
5 |
07/03/26 |
| 07/03/26 |
ASX - By Stock
|
88
|
33K
|
5
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: S&P DJI Announces March 2026 Quarterly Rebalance
|
|
Gsinc
|
88 |
33K |
6 |
06/03/26 |
| 06/03/26 |
ASX - By Stock
|
88
|
33K
|
6
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Appendix 4D and FY26 Half Year Report
|
|
Gsinc
|
107 |
37K |
6 |
04/03/26 |
| 04/03/26 |
ASX - By Stock
|
107
|
37K
|
6
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Appendix 4D and FY26 Half Year Report
|
|
Gsinc
|
107 |
37K |
4 |
03/03/26 |
| 03/03/26 |
ASX - By Stock
|
107
|
37K
|
4
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
3 |
03/02/26 |
| 03/02/26 |
ASX - By Stock
|
207
|
78K
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
2 |
03/02/26 |
| 03/02/26 |
ASX - By Stock
|
207
|
78K
|
2
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
3 |
03/02/26 |
| 03/02/26 |
ASX - By Stock
|
207
|
78K
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
7 |
02/02/26 |
| 02/02/26 |
ASX - By Stock
|
207
|
78K
|
7
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
5 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
207
|
78K
|
5
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
28 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
207
|
78K
|
28
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
3 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
207
|
78K
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
6 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
207
|
78K
|
6
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
0 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
207
|
78K
|
0
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
8 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
207
|
78K
|
8
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
10 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
207
|
78K
|
10
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Response to ASX Query Letter
|
|
Gsinc
|
207 |
78K |
1 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
207
|
78K
|
1
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: University of Chicago Medicine adopts CTVQ
|
|
Gsinc
|
19 |
8.1K |
5 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
19
|
8.1K
|
5
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Quarterly Activity Report and Appendix 4C
|
|
Gsinc
|
62 |
21K |
3 |
30/01/26 |
| 30/01/26 |
ASX - By Stock
|
62
|
21K
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Gsinc
|
5.1K |
2.3M |
14 |
29/01/26 |
| 29/01/26 |
ASX - By Stock
|
5.1K
|
2.3M
|
14
|
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Gsinc
|
5.1K |
2.3M |
11 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
5.1K
|
2.3M
|
11
|
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Gsinc
|
5.1K |
2.3M |
5 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
5.1K
|
2.3M
|
5
|
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Gsinc
|
5.1K |
2.3M |
36 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
5.1K
|
2.3M
|
36
|
|
|
ASX - By Stock
|
4DX |
Re:
Research
|
|
Gsinc
|
5.1K |
2.3M |
12 |
28/01/26 |
| 28/01/26 |
ASX - By Stock
|
5.1K
|
2.3M
|
12
|
|
|
ASX - By Stock
|
4DX |
Re:
Top 20 Academic Medical Centers Checklist CTVQ
|
|
Gsinc
|
119 |
48K |
1 |
25/01/26 |
| 25/01/26 |
ASX - By Stock
|
119
|
48K
|
1
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical completes $150 million institutional placement
|
|
Gsinc
|
292 |
103K |
3 |
24/01/26 |
| 24/01/26 |
ASX - By Stock
|
292
|
103K
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical completes $150 million institutional placement
|
|
Gsinc
|
292 |
103K |
9 |
24/01/26 |
| 24/01/26 |
ASX - By Stock
|
292
|
103K
|
9
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical completes $150 million institutional placement
|
|
Gsinc
|
292 |
103K |
25 |
24/01/26 |
| 24/01/26 |
ASX - By Stock
|
292
|
103K
|
25
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical completes $150 million institutional placement
|
|
Gsinc
|
292 |
103K |
9 |
23/01/26 |
| 23/01/26 |
ASX - By Stock
|
292
|
103K
|
9
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Investor Presentation
|
|
Gsinc
|
105 |
41K |
2 |
21/01/26 |
| 21/01/26 |
ASX - By Stock
|
105
|
41K
|
2
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Investor Presentation
|
|
Gsinc
|
105 |
41K |
13 |
19/01/26 |
| 19/01/26 |
ASX - By Stock
|
105
|
41K
|
13
|
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Clinical trial update at J.P. Morgan Healthcare Conference
|
|
Gsinc
|
55 |
18K |
2 |
17/01/26 |
| 17/01/26 |
ASX - By Stock
|
55
|
18K
|
2
|
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Clinical trial update at J.P. Morgan Healthcare Conference
|
|
Gsinc
|
55 |
18K |
1 |
16/01/26 |
| 16/01/26 |
ASX - By Stock
|
55
|
18K
|
1
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical completes $150 million institutional placement
|
|
Gsinc
|
292 |
103K |
6 |
15/01/26 |
| 15/01/26 |
ASX - By Stock
|
292
|
103K
|
6
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
2 |
14/01/26 |
| 14/01/26 |
ASX - By Stock
|
337
|
126K
|
2
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
9 |
14/01/26 |
| 14/01/26 |
ASX - By Stock
|
337
|
126K
|
9
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
3 |
14/01/26 |
| 14/01/26 |
ASX - By Stock
|
337
|
126K
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
12 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
337
|
126K
|
12
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
8 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
337
|
126K
|
8
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
8 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
337
|
126K
|
8
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
8 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
337
|
126K
|
8
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
5 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
337
|
126K
|
5
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
26 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
337
|
126K
|
26
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
4 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
337
|
126K
|
4
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
3 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
337
|
126K
|
3
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: Trading Halt
|
|
Gsinc
|
337 |
126K |
12 |
13/01/26 |
| 13/01/26 |
ASX - By Stock
|
337
|
126K
|
12
|
|
|
ASX - By Stock
|
4DX |
Re:
Ann: US DoD to conduct paid CT VQ pilot ahead of FDA submission
|
|
Gsinc
|
52 |
28K |
2 |
08/01/26 |
| 08/01/26 |
ASX - By Stock
|
52
|
28K
|
2
|
|